Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: Results of a European concerted action

Journal of Hepatology

Volumn 29, Issue 2, 1998, Pages 173-183

  Bréchot, Christian ^a   Jaffredo, Franck ^a   Lagorce, David ^a   Gerken, Guido ^b   Zum Büschenfelde, Karl Meyer ^b   Papakonstontinou, Anastasia ^c   Hadziyannis, Stephanos ^c   Romeo, Raffaela ^c   Colombo, Massimo ^c   Rodes, Joan ^c   Bruix, Jordi ^c   Williams, Roger ^c   Naoumov, Nikolai ^c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c NONE

Author keywords

HBV; HCC; HCV; HGV

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; EUROPE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENOME;

EID: 0032145740     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80001-9     Document Type: Article

References (72)

1. C Bréchot. Hepatitis B virus (HBV) and hepatocellular carcinoma. HBV DNA status and its implications. J Hepatol. 4:1987;269-279.
2. Kew MC. Role of cirrhosis in hepatocarcinogenesis. Bannasch P, Keppler D, Weber G. Liver Cell Carcinoma. 1989;37-45.
3. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 15:1992;948-963.
4. M Colombo. Hepatocellular carcinoma. J Hepatol. 15:1992;225-236.
5. Colombo M, Romeo R. Hepatitis C virus infection and hepatocellular carcinoma. Bréchot C. Primary Liver Cancer: Etiological and Progression Factor. 1994;49-56 CRC Press.
6. Paterlini P, Bréchot C. Hepatitis B virus and primary liver cancer in hepatitis B surface antigen-positive and negative patients. Bréchot C. Primary Liver Cancer: Ethiological and Progression Factors. 1994;167-190 CRC Press, Paris.
7. Shimotohno K. Hepatitis C virus as a causative agent of hepatocellular carcinoma. Intervirology. 38:1995;162-169.
8. Caselmann W, Alt M. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J Hepatol. 24:1996;61-66.
9. Bréchot C, Pol S. Hepatitis C virus biology and genetic variability: implications for the management of infected patients. Boyer J, Ockner RC. Progress in Liver Diseases. 1998;183-217 Kluwer Academic, Lancaster.
10. Hadziyannis S, Tabor E, Kaklamani E, Tzonou A, Stuver S, Tassopoulos N, et al. A case-control study of hepatitis B and C virus infections in the etiolgy of hepatocellular carcinoma. Int J Cancer. 60:1995;627-631.
11. Naoumov M, Chokshi S, Metivier E, Maertens G, Johnson P, Williams R. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. J Hepatol. 27:1997;331-336.
12. Bréchot C. Molecular mechanisms of hepatitis B and C viruses related liver carcinogenesis. Rizzetto M. IX Triennal International Symposium on Viral Hepatitis and Liver Diseases. 1998;. in press.
13. Bruix J, Banera J, Calvet X, Ercilla G, Costa J, Sanches-Tapias J, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. ii:1989;1004-1006.
14. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology. 16:1992;637-641.
15. Nishioka K, Watanabe J, Furata S, Tanaka E, Iino S, Suzuki H, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer. 2:1991;429-433.
16. C Bréchot, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative test for hepatitis B surface antigen. N Engl J Med. 312:1985;270-276.
17. Coursaget P, Le Cann P, Leboulleux D, Diop MT, Bao O, Coll AM. Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Senegalese patients suffering from cirrhosis or primary liver cancer. FEMS Letter. 35-38:1991.
18. Feitelson Ma, Duan LX, Guo J, Sun B, Woo J, Steensma K, et al. X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis. J Infect Dis. 172:1995;713-722.
19. Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, et al. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology. 18:1993;1326-1333.
20. Paterlini P, Gerken G, Nakajima E. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancer from patients negative for hepatitis B surface antigen. N Engl J Med. 323:1990;80-85.
21. Rasenack JW, Schlayer HJ, Hettler F, Peters T, Preisler-Adams S, Gerok W. Hepatitis B virus infection without immunological markers after open-heart surgery. Lancet. 345:1995;355-357.
22. Urashima T, Saigo K, Kobayashi S, Imaseki H, Matsubara H, Koide Y, et al. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues. J Hepatol. 26:1997;771-778.
23. Simons J, Leary T, Dawson G, Pilot-Matias T, Muerhoff A, Schlauder G, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature. 1:1995;564-569.
24. Linnen J, Wages J, Zhanf-Keck Z-Y, Fry K, Krawczynski K, Alter H, et al. Molecular cloning and disease association of hepatitis C virus: a transfusion-transmissible agent. Science. 271:1996;505-508.
25. Tagger A, Donato F, Ribero ML, Chiesa R, Tomasoni V, Portera G, et al. A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Brescia HCC study. Hepatology. 26:1997;1653-1657.
26. Paterlini P, Poussin K, Kew M, Franco D, Bréchot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology. 21:1995;313-321.
27. Thiers V, Lunel F, Valla D, Azar N, Fretz C, Frangeul L, et al. Post-transfusional anti-HCV negative non-A non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses. J Hepatol. 18:1993;34-39.
28. Thiers V, Jaffredo F, Tuveri R, Chodan N, Bréchot C. Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping tests. J Virol Meth. 65:1997;9-17.
29. Gerken G, Pontisso P, Roggenford M, Rumi MG, Simmonds P, et al. Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA. J Hepatol. 24:1996;33-37.
30. Kew M, Houghton M, Choo Q, Kuo G. Hepatitis C virus antibodies in Southern African blacks with hepatocellular carcinoma. Lancet. i:1990;893.
31. Dazza M, Meneses L, Girard P, Villaroel C, Bréchot C, Larouze B. Hepatitis C virus antibody and hepatocellular carcinoma. Lancet. 335:1990;1216.
32. Okuno H, Xie Z-C, Lu B-Y, Qin X, Takasu M, Kano H, et al. a low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi province Southern China. Cancer. 73:1994;57-62.
33. Lai MY, Chen PJ, Yang PM, Sheu JC, Sung JL, Chen DS. Identification and characterisation of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan. Hepatology. 12:1990;575-581.
34. Blum H, Liang J, Galun E, Wands J. Persistence of hepatitis B virus DNA after serological recovery from hepatitis B virus infection. Hepatology. 14:1991;56-63.
35. Preisler-Adams S, Schlayer HJ, Peters T, Hettler F, Gerok W, Rasenack J. Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch Virol. 133:1993;385-396.
36. Uchida T, Shimojima M, Gotoh K, Shikata T, Tanaka E, Kiyosawa K. "Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol Immunol. 38:1994;281-285.
37. Jilg W, Sieger E, Zachoval R, Schätz H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol. 23:1995;14-20.
38. Wands J, Fujita Y, Isselbacher K, Degott C, Schellekens H, Dazza M, et al. Identification and transmission of hepatitis B virus-related variants. Proc Natl Acad Sci USA. 83:1986;660/-6612.
39. Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, et al. Transmission of hepatitis B from seronegative subjects. Lancet. ii:1988;1273-1276.
40. Baginski I, Chemin I, Hantz O. Transmission of serologically silent hepatitis B virus along with hepatitis V virus in two cases of posttransfusion hepatitis. Transfusion. 32:1992;215-220.
41. Chazouillères O, Mamish D, Kim M. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet. 343:1994;142-146.
42. Gotoh K, Mima S, Uchida T, Shicata T, Yoshizawa K, Iri M, et al. Nucleotide sequence of hepatitis B virus isolated from subjects without serum anti-hepatitis B core antibody. J Med Virol. 46:1995;201-206.
43. Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas H. A unique insertion in the S gene of surface antigen negative hepatitis B virus Chinese carriers. Hepatology. 21:1995;273-278.
44. Kremsdorf D, Garreau F, Duclos H, Thiers V, Schellekens H, Petit MA, et al. Complete nucleotide sequence and viral envelope protein expression of a hepatitis B virus DNA derived from a hepatitis B surface antigen-seronegative patient. J Hepatol. 18:1993;244-250.
45. Repp R, Keller C, Borkhardt A, Csecke A, Schafer S, Gerlich W. Detection of a hepatitis B virus variant with a truncated X gene and enhancer II. Arch Virol. 125:1992;299-304.
46. Uchida T, Gotoch K, Shikata T. Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically negative acute or chronic hepatitis. J Med Virol. 45:1995;247-252.
47. Poussin K, Dienes H, Sirma H, Urban S, Beaugrand M, Schirmacher P, et al. Expression of mutated hepatitis B virus X gene in human hepatocellular carcinomas. Hepatology. 22:1995;193A.
48. Minami M, Poussin K, Kew M, Okanoue T, Bréchot C, Paterlini P. Precore/core mutations of hepatitis B virus in hepatocellular carinomas developed on noncirrhotic livers. Gastroenterology. 111:1996;691-700.
49. Ganne-Carrie N, Kremsdorf D, Garreau F, Thevenin M, Petit MA, Nalpas B, et al. Effects of ethanol on hepatitis B virus PRE/S/S genes expression in the human hepatocellular carcinoma derived HepG2 cell line. J Hepatol. 23:1995;153-159.
50. Adachi H, Kaneko S, Matsushita E, Inagaki Y, Unoura M, Kobayashi K. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology. 15:1992;1334-1337.
51. Hsu H-Y, Chang M-H, Lee C-Y, Chen J-S, Hsu H-C, Chen D-C. Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology. 15:1992;382-386.
52. Mason A, Yoffe B, Noonan C, Mearns M, Campbell C, Kelley A, et al. Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance. Hepatology. 16:1992;36-41.
53. Michalak TI, Pasquinelli C, Guillot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 93:1994;230-239.
54. Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M, et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest. 98:1996;1185-1194.
55. Koike K. Hepatitis B virus HBx gene and hepatocarcinogenesis. Intervirology. 38:1995;134-142.
56. Buendia MA. Animal models for hepatitis B virus and liver cancer. Bréchot C. Primary Liver Cancer: Etiological and Progression Factors. 1994;211-224 CRC Press, Paris.
57. Gerin J, Cote P, Korba B, Miller R, Purcell R, Tennant B. Hepatitis B virus and liver cancer: the woodchuck as an experimental model of hepadnavirus-induced liver cancer. Hollinger FB, Lemon SM, Margolis H. Viral Hepatitis and Liver Disease. 1991;556-559 williams and Wilkins, Baltimore.
58. Korba BE, Wells FV, Baldwin B, Cote PJ, Tennant BC, Popper H, et al. Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology. 9:1989;461-470.
59. Yu MC, Yuan JM, Ross RK, Govindarajan S. Presence of antibodies to the hepatitis B surface antigen associated with an excess risk for hepatocellular crcnoma among non-Asians in Los Angeles county, California. Hepatology. 25:1997;226-228.
60. Bréchot C. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma. Hepatology. 25:1997;772-774.
61. De Mitri S, Poussin K, Baccarini P. HCV-associated liver cancer without cirrhosis. Lancet. 345:1995;413-415.
62. Elrefaie A, Savage K, Bhattacharya S, Khakoo S, Harrison T, Elbatanomy M, et al. HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol. 24:1996;277-285.
63. Ray RB, Martin Lagging L, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol. 70:1996;4438-4443.
64. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol. 69:1995;3893-3896.
65. Hatzakis A, Katsoulidou A, Kaklami E, Touloumi G, Koumantaki Y, Tassopoulos N, et al. Hepatitis C Virus 1b is the dominant genotype in HCV-related carcinogenesis-a case-control study. Int J Cancer. 68:1996;51-53.
66. Nousbaum J, Pol S, Nalpas B, Landais P, Berthelot P, Kreis H, et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med. 122:1995;161-168.
67. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology. 105:1993;1529-1533.
68. Tsai J-F, Chang WY, Jeng J-E, Ho M-S, Lin Z-Y, Tsai J-H. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Virol. 44:1994;92-95.
69. Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, et al. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Cancer Epidemiol Biomarkers Prev. 5:1996;173-178.
70. Pessoa M, Terrault N, Ferrel L, Kim J, Kolberg J, Collins M, et al. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology. 25:1997;1266.
71. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JWK, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med. 336:1997;747-754.
72. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Lack evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol. 71:1997;7804-7806.